Drug Profile
Alpha galactosylceramide - Kyowa Kirin
Alternative Names: AGL 582; Alpha-galactosylceramide; KRN-7000Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Kirin Pharma Company
- Developer Kyowa Hakko Kirin
- Class Adjuvants; Antineoplastics; Galactosylceramides; Small molecules
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B; Hepatitis C; Lung cancer
Most Recent Events
- 01 Jul 2019 Kyowa Hakko Kirin is now called Kyowa Kirin
- 17 Jan 2013 Discontinued - Phase-I/II for Hepatitis C in European Union (IV)
- 17 Jan 2013 Discontinued - Phase-II for Hepatitis B in European Union (IV)